Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Gray Sheet

Executive Summary

Given Imaging’s PillCam SB

You may also be interested in...



FDA Assembling Advisors To Discuss Pediatric HDE Products

As part of a periodic review, FDA is bringing together experts to review several products that are conditionally available for pediatric use under the agency's Humanitarian Device Exemption program.

Medtronic Sees A Future In Extreme Miniature

Device manufacturers are eyeing a miniature future as they design next-generation implants and treatments, from tiny glucose sensors for diabetics to small wireless monitors that could remotely track blood pressure, weight and heart rate.

Medtronic Sees A Future In Extreme Miniature

Device manufacturers are eyeing a miniature future as they design next-generation implants and treatments, from tiny glucose sensors for diabetics to small wireless monitors that could remotely track blood pressure, weight and heart rate.

Topics

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel